Live Breaking News & Updates on Reflecting Revised Net Sales Expectations|Page 1

Stay updated with breaking news from Reflecting revised net sales expectations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Horizon Therapeutics plc Reports Second-Quarter 2022 Financial Results and Revises Full-Year 2022 Ne

Second-Quarter 2022 Results: Net Sales of $876.4 Million; Orphan Segment Net Sales Increased 13% to $841.3 Million GAAP Net Income of $61.0 Million; Adjusted EBITDA of $306.6 Million TEPEZZA® (teprotumumab-trbw) Net Sales of $479.8 Million KRYSTEXXA® (pegloticase injection) Net Sales of $167.8 Milli. ....

United States , Ruth Venning , Tim Walbert , Tina Ventura , Geoff Curtis , Erin Linnihan , Subcutaneous Sc Administration Trial , Alkem Laboratories Inc , Communications Officer , Corporate Affairs , Apotex Inc , Orphan Segment Net Sales Increased , Net Sales , Sales Guidance , Reflecting Revised Net Sales Expectations , Sales Percentage Growth , Company Highlights , Include Co Administration , Methotrexate Based , That Demonstrated Improved , Sustained Patient , European Commission , Adult Patients , Commercial Launch Underway , Horizon Therapeutics , Recent Company ,